The National Institutes of Health NIH has awarded a five-year, $28 million grant to establish a new center for excellence to find an antibody “cocktail” to fight two types of viruses that cause severe hemorrhagic fever, including the Ebola virus. The project involves researchers from 15 institutions, including Thomas Geisbert at UTMB. The project will be led by The Scripps Research Institute.